Jochen Gaedcke[Author] - Search Results

Year	Number of Results
2006	1
2007	1
2008	1
2009	5
2010	9
2011	5
2012	8
2013	9
2014	5
2015	9
2016	9
2017	5
2018	4
2019	10
2020	7
2021	12
2022	12
2023	9
2024	6

1

ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer.

Ohara Y, Liu H, Craig AJ, Yang S, Moreno P, Dorsey TH, Cawley H, Azizian A, Gaedcke J, Ghadimi M, Hanna N, Ambs S, Hussain SP. Ohara Y, et al. Among authors: gaedcke j. Int J Cancer. 2024 Apr 17. doi: 10.1002/ijc.34960. Online ahead of print. Int J Cancer. 2024. PMID: 38630934

2

MIF/NR3C2 Axis Regulates Glucose Metabolism Reprogramming in Pancreatic Cancer through MAPK-ERK and AP-1 Pathways.

Yang S, Tang W, Azizian A, Gaedcke J, Ohara Y, Cawley H, Hanna N, Ghadimi BM, Lal T, Sen S, Creighton CJ, Gao J, Putluri N, Ambs S, Hussain SP. Yang S, et al. Among authors: gaedcke j. Carcinogenesis. 2024 Apr 17:bgae025. doi: 10.1093/carcin/bgae025. Online ahead of print. Carcinogenesis. 2024. PMID: 38629149

3

Short- and Long-Term Outcomes of Patients with Postoperative Arrhythmia after Liver Surgery.

Rühlmann F, Engelhardt D, Mackert AF, Hedicke MS, Tichelbäcker T, Leha A, Bernhardt M, Ghadimi M, Perl T, Azizian A, Gaedcke J. Rühlmann F, et al. Among authors: gaedcke j. Biomedicines. 2024 Jan 25;12(2):271. doi: 10.3390/biomedicines12020271. Biomedicines. 2024. PMID: 38397873 Free PMC article.

4

Perioperative LiMAx Test Analysis: Impact of Portal Vein Embolisation, Chemotherapy and Major Liver Resection.

Rühlmann F, Azizian A, Moosmann C, Bernhardt M, Keck J, Flebbe H, Al-Bourini O, Hosseini ASA, Grade M, Lorf T, Ghadimi M, Perl T, Gaedcke J. Rühlmann F, et al. Among authors: gaedcke j. Biomedicines. 2024 Jan 23;12(2):254. doi: 10.3390/biomedicines12020254. Biomedicines. 2024. PMID: 38397856 Free PMC article.

5

LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism.

Ohara Y, Craig AJ, Liu H, Yang S, Moreno P, Dorsey TH, Cawley H, Azizian A, Gaedcke J, Ghadimi M, Hanna N, Ambs S, Hussain SP. Ohara Y, et al. Among authors: gaedcke j. Carcinogenesis. 2024 Feb 15:bgae011. doi: 10.1093/carcin/bgae011. Online ahead of print. Carcinogenesis. 2024. PMID: 38366633

6

Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection.

Bernhardt M, Rühlmann F, Azizian A, Kölling MA, Beißbarth T, Grade M, König AO, Ghadimi M, Gaedcke J. Bernhardt M, et al. Among authors: gaedcke j. Biomedicines. 2023 Nov 11;11(11):3025. doi: 10.3390/biomedicines11113025. Biomedicines. 2023. PMID: 38002027 Free PMC article.

7

SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer.

Ohara Y, Tang W, Liu H, Yang S, Dorsey TH, Cawley H, Moreno P, Chari R, Guest MR, Azizian A, Gaedcke J, Ghadimi M, Hanna N, Ambs S, Hussain SP. Ohara Y, et al. Among authors: gaedcke j. Cell Rep. 2023 Dec 26;42(12):113434. doi: 10.1016/j.celrep.2023.113434. Epub 2023 Nov 18. Cell Rep. 2023. PMID: 37980563 Free PMC article.

8

Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial.

Rau B, Lang H, Koenigsrainer A, Gockel I, Rau HG, Seeliger H, Lerchenmueller C, Reim D, Wahba R, Angele M, Heeg S, Keck T, Weimann A, Topp S, Piso P, Brandl A, Schuele S, Jo P, Pratschke J, Wegel S, Rehders A, Moosmann N, Gaedcke J, Heinemann V, Trips E, Loeffler M, Schlag PM, Thuss-Patience P. Rau B, et al. Among authors: gaedcke j. J Clin Oncol. 2024 Jan 10;42(2):146-156. doi: 10.1200/JCO.22.02867. Epub 2023 Oct 31. J Clin Oncol. 2024. PMID: 37906724 Free PMC article. Clinical Trial.

9

Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer.

Digomann D, Heiduk M, Reiche C, Glück J, Kahlert C, Mirtschink P, Klimova A, Bösch F, Tonn T, Gaedcke J, Ghadimi M, Weitz J, Seifert L, Seifert AM. Digomann D, et al. Among authors: gaedcke j. NPJ Precis Oncol. 2023 Oct 14;7(1):104. doi: 10.1038/s41698-023-00459-9. NPJ Precis Oncol. 2023. PMID: 37838778 Free PMC article.

10

Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal Adenocarcinoma.

Wang X, Kutschat AP, Aggrey-Fynn J, Hamdan FH, Graham RP, Wixom AQ, Souto Y, Ladigan-Badura S, Yonkus JA, Abdelrahman AM, Alva-Ruiz R, Gaedcke J, Ströbel P, Kosinsky RL, Wegwitz F, Hermann P, Truty MJ, Siveke JT, Hahn SA, Hessmann E, Johnsen SA, Najafova Z. Wang X, et al. Among authors: gaedcke j. Mol Cancer Res. 2023 Sep 1;21(9):881-891. doi: 10.1158/1541-7786.MCR-22-0916. Mol Cancer Res. 2023. PMID: 37279184 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

112 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year